ENVERIC BIOSCIENCES, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $75.04K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $33.47K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2021 was $33.47K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2019 was $88.47K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2017 was $217.00K, a 92.77% decline from fiscal 2016.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2016 was $3.00M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-03-31 | $75.04K 10-Q · filed 2025-08-14 | |
| 2021-12-31 | $33.47K 10-K/A · filed 2023-06-09 | |
| 2021-06-30 | $33.47K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $88.47K 10-K · filed 2021-04-01 | |
| 2017-12-31 | $217.00K 10-K · filed 2019-03-26 | |
| 2016-12-31 | $3.00M 10-K/A · filed 2017-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |